News

Gannex’s Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH USA – English APAC – Traditional Chinese

by

Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial of 168 NASH patients with stage 2 or 3 fibrosis –  Primary efficacy endpoints: NASH resolution without worsening of fibrosis with ≥2-point reduction in NAS (NAFLD Activity Score) in 36% of denifanstat-treated patients vs 13% with placebo (p=0.002) ≥2-point reduction … Read more

Publication of data from WIL-31 study marks a milestone in improving long-term care for patients with severe von Willebrand disease (VWD)

by

WIL-31 is the largest prospective prophylaxis study in VWD WIL-31 is the only study in VWD with a prospective on-demand run-in study as an intra-individual comparator wilate® prophylaxis is highly effective at reducing bleeding rates in children and adults with all types of VWD vs prior on-demand treatment LACHEN, Switzerland, Jan. 22, 2024 /PRNewswire/ — Octapharma … Read more

Antibody Therapeutics Market Size to Grow USD 364180 Million by 2029 at a CAGR of 11%

by

BANGALORE, India, Jan. 21, 2024 /PRNewswire/ — Antibody Based Therapeutics Market is Segmented by Type (Monoclonal Antibodies, Bi-Specific Antibodies Therapy, Antibody-drug Conjugates), by Application (Immune Diseases, Cancer): Global Opportunity Analysis and Industry Forecast, 2023-2029. It is Published in Valuates Reports Under the Category of Pharmaceuticals & Biotech. Antibody Based Therapeutics Market is projected to reach USD … Read more

First-Ever Treatment for Ultra-Rare Rapid-Aging Disease Progeria Receives Approval in Japan

by

The Progeria Research Foundation Marks Significant Achievement as Zokinvy™ (lonafarnib) Receives Japanese Approval for the Treatment of Progeria and Processing-Deficient Progeroid Laminopathies PEABODY, Mass., Jan. 20, 2024 /PRNewswire/ — The Progeria Research Foundation (PRF) today announced a new milestone with the approval of Zokinvy™ (lonafarnib) by the Japanese Ministry of Health, Labor and Welfare (MHLW), for … Read more

Global Vaginal Rejuvenation (Reconstructive, Cosmetic) Research Report 2023-2030

by

DUBLIN, Jan. 19, 2024 /PRNewswire/ — The “Global Vaginal Rejuvenation Market Size, Share & Trend Analysis By Treatment Type (Reconstructive, Cosmetic), Type, Application, Age Category, Region and Segment Forecasts, 2024-2030” report has been added to ResearchAndMarkets.com’s offering. The global vaginal rejuvenation market size is expected to reach USD 14.34 billion by 2030, registering a CAGR of 22.07% from … Read more

Cynosure and Lutronic Announce Merger to Create a Leading Global Medical Aesthetics Technology Company

by

WESTFORD, Mass. and BILLERICA, Mass., Jan. 19, 2024 /PRNewswire/ — Cynosure and Hahn & Company, which has recently acquired Lutronic, announced today that they have entered into a definitive merger agreement for a strategic combination of Cynosure and Lutronic. Both Cynosure and Lutronic are global providers of energy-based medical aesthetic treatment systems and related technologies. … Read more

Global Bioanalytical Testing Services Market Set to Double, Reaching $6.6 Billion by 2028, BCC Research Study Finds

by

Latest BCC Research Report Predicts a Robust 15.2% CAGR for Bioanalytical Testing Services, Expanding from $3.2 Billion in 2023  BOSTON, Jan. 18, 2024 /PRNewswire/ — The Global Bioanalytical Testing Services Market is a dynamic and essential sector within the healthcare and pharmaceutical industries. Focused on evaluating and interpreting biological substances, these services play a critical … Read more

Veeva finalise la migration des études vers Veeva Vault EDC pour une entreprise biopharmaceutique de premier plan

by

Pour la première fois dans l’industrie, toutes les études en cours ont été transférées de l’ancien EDC vers Vault EDC. BARCELONE, Espagne, 17 janvier 2024 /PRNewswire/ — Veeva Systems (NYSE: VEEV) a annoncé aujourd’hui que l’une des 20 plus grandes entreprises biopharmaceutiques et Veeva Services ont migré 25 études cliniques en cours vers Veeva Vault EDC à partir d’une ancienne … Read more

Auburn Engineering faculty start-up VivoSphere™ nominated for prestigious Ignite Award

by

AUBURN, Ala., Jan. 16, 2024 /PRNewswire/ — VivoSphere, a biomedical engineering start-up founded by two Auburn University chemical engineering researchers that created a precise, cost-effective test bed for high-throughput, pre-clinical evaluation of critical cancer therapy candidates, has been selected as one of the most promising new ventures in the bio-diagnostics industry. The New Venture Accelerator company was nominated … Read more

Brain Navi Announces 100th Surgical Procedure Completed Using NaoTrac

by

HSINCHU, Jan. 15, 2024 /PRNewswire/ — Brain Navi announced the completion of the 100th case utilizing its neurosurgical navigation robot NaoTrac. The 100th case has been performed by Neurosurgery Department Director Dr. Hao-Yu Chuang at Annan Hospital in Tainan, Taiwan. Brain Navi Completed 100th Surgical Procedure Using NaoTrac “It is my pleasure to be witnessing this … Read more